Paul-Henri Consigny

Paul-Henri Consigny is a Researcher at the Pasteur Institute in Paris, France. He serves as Principal Investigator (PI) for multiple projects focused on infectious disease dynamics in travelers and humanitarian workers, including rabies exposure prophylaxis, multidrug-resistant Enterobacteriaceae acquisition, and hidradenitis suppurativa treatment protocols.

Research Interests include:

• Travel-associated infectious risks
• Antibiotic resistance in tropical regions
• Vaccine efficacy in immunocompromised populations
• Clinical management of zoonotic diseases
• Epidemiological modeling of pathogen transmission
• Public health interventions for high-risk travelers

Recent Publications highlight his work on rabies prophylaxis (2025), multidrug-resistant bacteria in travelers (2024), and hidradenitis suppurativa antibiotic regimens (2020). His studies often involve multinational collaborations through networks like GeoSentinel and InterVax.

Project Leadership spans:

• Rabies Prophylaxis (PI, 2018-2022)
• GeoSentinel Disease Surveillance (ongoing)
• Humanitarian Worker Health Studies (PI, completed)
• Monkeypox Clinical Management (PI, ongoing)
• ABCESS2 Hidradenitis Suppurativa Trial (PI, not started)